Most goiters are not cancerous. The majority of thyroid enlargements are caused by benign conditions like iodine deficiency, autoimmune thyroid disease, or harmless nodules. However, a meaningful percentage of goiters do contain cancer, which is why doctors evaluate them carefully rather than assuming they’re safe.
The cancer rate in goiters varies widely depending on the population studied and how thoroughly the tissue is examined. Older research placed the rate around 3%, while more recent surgical studies have found thyroid cancer in up to 31 to 35% of patients who had a multinodular goiter removed. That higher number reflects the fact that people who end up in surgery tend to have more suspicious features to begin with, so it doesn’t mean one in three goiters is cancerous overall. Still, the numbers are high enough that any goiter with nodules deserves a proper workup.
Single Nodules vs. Multinodular Goiters
There’s a long-standing belief that goiters with multiple nodules carry a lower cancer risk than a single, solitary nodule. On the surface, some data supports this: in one study of 600 patients, cancer was found in about 41% of solitary nodules compared to 29% of multinodular goiters. But when researchers controlled for other variables like gender and the initial clinical suspicion, the difference disappeared. The conclusion: a multinodular goiter carries roughly the same cancer risk as a single nodule, so having multiple nodules shouldn’t be treated as reassuring on its own.
What Type of Cancer Is Most Common
When cancer is found in a goiter, it’s overwhelmingly papillary thyroid carcinoma, accounting for about 57 to 64% of malignant cases. This is also the most treatable form. Most papillary thyroid cancers are small, slow-growing, and respond well to treatment, even when cancer cells have spread to nearby lymph nodes in the neck.
Follicular carcinoma is the second most common type, making up roughly 26% of cancers found in multinodular goiters. It tends not to spread to lymph nodes but can occasionally reach more distant organs. Medullary carcinoma is less common, around 7% of cases. Anaplastic thyroid cancer is rare but aggressive, grows quickly, and tends to appear in people over 60.
Signs That Raise Concern
Most goiters cause no symptoms at all, and many are discovered incidentally during imaging for something else. But certain features make cancer more likely and should prompt a closer look:
- A hard, fixed lump that feels different from the soft, movable texture of most benign nodules
- Hoarseness or voice changes that develop without another explanation, which can signal a nodule pressing on or invading the nerve that controls your vocal cords
- Difficulty swallowing or breathing that worsens over weeks
- Swollen lymph nodes in the neck
- Rapid growth of the goiter or a nodule within it
- Neck or throat pain that doesn’t resolve
A goiter that has been stable for years and causes no symptoms is far less worrisome than one that appears suddenly or changes quickly. Anaplastic thyroid cancer, though rare, can cause neck swelling that worsens dramatically over days and leads to breathing difficulty.
Risk Factors for a Cancerous Goiter
Radiation exposure is the most well-established environmental risk factor for thyroid cancer. The risk increases with higher radiation doses to the thyroid gland, and childhood exposure is far more dangerous than exposure in adulthood. People who received radiation therapy to the head, neck, or chest as children, or who were exposed to nuclear fallout (as happened after the Chernobyl disaster), have a significantly elevated risk. After Chernobyl, young children developed aggressive forms of papillary thyroid cancer with a relatively short lag time between exposure and diagnosis.
Other factors that increase risk include a family history of thyroid cancer, iodine deficiency (which forces the thyroid to work harder and take up more radioactive iodine if exposed), and a BMI over 25. Chemotherapy during childhood roughly quadruples the risk of later thyroid cancer, and the risk is additive when chemotherapy and radiation are combined.
How Doctors Evaluate a Goiter
The first step is usually an ultrasound, which lets doctors see the size, shape, and internal structure of any nodules. Radiologists score nodules using a system called TI-RADS, which assigns points based on features like irregular borders, tiny calcium deposits, and whether the nodule is taller than it is wide. The score determines whether a biopsy is recommended and at what size threshold.
For nodules that look highly suspicious on ultrasound (the highest risk category), a biopsy is typically recommended once the nodule reaches 1 centimeter. For moderately suspicious nodules, the threshold rises to 1.5 centimeters. Mildly suspicious nodules generally aren’t biopsied unless they reach 2.5 centimeters. Nodules that appear clearly benign on imaging usually don’t require a biopsy at all.
The biopsy itself is a fine needle aspiration, where a thin needle is inserted into the nodule to collect cells for examination under a microscope. A large meta-analysis covering over 16,000 patients found this test correctly identifies cancer about 87% of the time. Its specificity, the ability to correctly rule out cancer, is lower at around 73%, meaning some benign nodules get flagged as suspicious and may need further testing or follow-up.
What Happens if a Goiter Is Benign
A goiter confirmed as benign often requires no treatment at all. If it’s small and not causing symptoms, your doctor may simply monitor it with periodic ultrasounds to check for changes. Many benign goiters stay the same size for years.
Treatment becomes relevant when a benign goiter grows large enough to cause problems. A goiter that presses on your airway, esophagus, or blood vessels can make it hard to breathe or swallow, and surgery to remove part or all of the thyroid is the standard approach in those cases. Large multinodular goiters that extend behind the breastbone are especially likely to need surgical removal. After surgery, you may need to take thyroid hormone replacement daily if enough thyroid tissue is removed to affect hormone production.
What Happens if Cancer Is Found
For the most common types of thyroid cancer, the outlook is very good. Papillary thyroid cancer, even when it has spread to neck lymph nodes, responds well to treatment and has high survival rates. Treatment typically involves surgical removal of the thyroid, sometimes followed by radioactive iodine therapy to destroy any remaining thyroid cells.
After treatment, follow-up visits are important because thyroid cancer recurrence, when it happens, most often appears within the first five years. Recurrence can show up in leftover thyroid tissue, neck lymph nodes, or occasionally in the lungs or bones. Monitoring involves periodic blood tests and ultrasounds, and your doctor will ask about symptoms like new neck lumps, voice changes, or difficulty swallowing. More aggressive types like anaplastic or Hurthle cell carcinoma carry a different prognosis and may require more intensive treatment, but these are uncommon.